文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

心脏植入式电子设备接受者的综合多组分心脏康复:来自欧洲预防心脏病学协会 (EAPC;二级预防和康复分会) 和欧洲心律协会 (EHRA) 的共识文件。

Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA).

机构信息

Cardiovascular Department, IRCCS MultiMedica, Care and Research Institute, Via Milanese 300, Sesto San Giovanni, Milano 20099, Italy.

Department of Cardiac Rehabilitation and Secondary Prevention, Hôpital Corentin Celton, Assistance Pulique Hopitaux de Paris centre-Universite de Paris, France.

出版信息

Europace. 2021 Sep 8;23(9):1336-1337o. doi: 10.1093/europace/euaa427.


DOI:10.1093/europace/euaa427
PMID:33636723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11636569/
Abstract

Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment and medical actions to promote stabilization, management of cardiovascular risk factors, vocational support, psychosocial management, physical activity counselling, and prescription of exercise training. Millions of people with cardiac implantable electronic devices live in Europe and their numbers are progressively increasing, therefore, large subsets of patients admitted in CR facilities have a cardiac implantable electronic device. Patients who are cardiac implantable electronic devices recipients are considered eligible for a CR programme. This is not only related to the underlying heart disease but also to specific issues, such as psychological adaptation to living with an implanted device and, in implantable cardioverter-defibrillator patients, the risk of arrhythmia, syncope, and sudden cardiac death. Therefore, these patients should receive special attention, as their needs may differ from other patients participating in CR. As evidence from studies of CR in patients with cardiac implantable electronic devices is sparse, detailed clinical practice guidelines are lacking. Here, we aim to provide practical recommendations for CR in cardiac implantable electronic devices recipients in order to increase CR implementation, efficacy, and safety in this subset of patients.

摘要

心脏康复(CR)是一种多学科干预措施,包括患者评估和医疗措施,以促进稳定、心血管危险因素的管理、职业支持、心理社会管理、身体活动咨询以及运动训练的处方。数以百万计的欧洲人患有心脏植入式电子设备,而且这个数字还在不断增加,因此,在心脏康复设施中接受治疗的患者中有很大一部分人都有心脏植入式电子设备。被认为有资格参加心脏康复计划的是那些心脏植入式电子设备的接受者。这不仅与潜在的心脏病有关,还与特定问题有关,例如对植入设备的心理适应,以及在植入式心脏复律除颤器患者中,心律失常、晕厥和心脏性猝死的风险。因此,这些患者应该得到特别关注,因为他们的需求可能与其他参加心脏康复的患者不同。由于心脏植入式电子设备患者心脏康复的研究证据很少,因此缺乏详细的临床实践指南。在这里,我们旨在为心脏植入式电子设备接受者的心脏康复提供实用建议,以提高这部分患者的心脏康复实施、疗效和安全性。

相似文献

[1]
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA).

Europace. 2021-9-8

[2]
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA).

Eur J Prev Cardiol. 2021-12-29

[3]
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).

JACC Clin Electrophysiol. 2021-11

[4]
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.

Cardiol Young. 2021-11

[5]
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Europace. 2020-4-1

[6]
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Eur J Cardiothorac Surg. 2020-1-1

[7]
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.

Heart Rhythm. 2021-11

[8]
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).

Eur J Heart Fail. 2024-2

[9]
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Eur Heart J. 2020-6-1

[10]
Imaging in patients with cardiovascular implantable electronic devices: part 1-imaging before and during device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC.

Eur Heart J Cardiovasc Imaging. 2023-12-21

引用本文的文献

[1]
Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions.

CJC Open. 2025-3-3

[2]
STEPWISE CARDIAC REHABILITATION ADJUSTMENT AFTER EXERCISE-INDUCED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK: A CASE REPORT.

J Rehabil Med Clin Commun. 2025-4-16

[3]
Summary of the best evidence for risk stratification of exercise rehabilitation in patients with a cardiac implantable electronic device.

Front Cardiovasc Med. 2024-11-25

[4]
Identifying Elements for a Cardiac Rehabilitation Program for Caregivers: An International Delphi Consensus.

Healthcare (Basel). 2024-10-16

[5]
Cardiac Rehabilitation to Inpatient Heart Transplant-HRN4HTx Intervention Protocol.

Nurs Rep. 2024-8-23

[6]
Psychological factors associated with exercise self-efficacy in the recipients of an implantable cardioverter defibrillator.

PLoS One. 2024

[7]
Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.

J Am Heart Assoc. 2023-8

[8]
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.

Int J Heart Fail. 2023-4-10

[9]
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.

Korean Circ J. 2023-4

[10]
Clinical Determinants and Barriers to Cardiac Rehabilitation Enrollment of Patients with Heart Failure with Reduced Ejection Fraction: A Single-Center Study in Portugal.

J Cardiovasc Dev Dis. 2022-10-9

本文引用的文献

[1]
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology.

Eur J Prev Cardiol. 2021-5-14

[2]
The 'Ten Commandments' for the 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease.

Eur Heart J. 2021-1-1

[3]
Exercise stress test methodology and safety in hypertrophic cardiomyopathy.

Eur J Prev Cardiol. 2020-11

[4]
Exercise and myocardial injury in hypertrophic cardiomyopathy.

Heart. 2020-8

[5]
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy.

Eur J Prev Cardiol. 2020-11

[6]
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Eur Heart J. 2020-1-14

[7]
Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference.

HeartRhythm Case Rep. 2019-1-30

[8]
High-intensity interval training in cardiac resynchronization therapy: a randomized control trial.

Eur J Appl Physiol. 2019-5-23

[9]
[Cardiac implantable electronic devices : Electromagnetic interference from electrocauterization, lithotripsy and physiotherapy].

Herzschrittmacherther Elektrophysiol. 2019-6

[10]
Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study.

J Psychosom Res. 2019-3-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索